These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18630056)

  • 1. [Toxidermia during antiretroviral therapy in Conakry, Guinea].
    Cisse M; So N; Keita M; Soumah MM; Camara A
    Med Trop (Mars); 2008 Apr; 68(2):203. PubMed ID: 18630056
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous drug reactions associated with newer antiretroviral agents.
    Martins CR
    J Drugs Dermatol; 2006; 5(10):976-82. PubMed ID: 17373147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous side effects of antiretroviral drugs].
    Kane A; Niang S; Kébé M; Ly F; Diallo M; Dieng MT; Ndiaye B
    Mali Med; 2007; 22(1):22-5. PubMed ID: 19617109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridemia in antiretroviral therapy.
    Imarhiagbe FA; Kubeyinje EP
    MedGenMed; 2005 Sep; 7(3):65. PubMed ID: 16369291
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiretroviral therapy and the prevalence and incidence of diabetes.
    Mikhail N; Cope D
    Arch Intern Med; 2005 Nov; 165(21):2536-7; author reply 2537. PubMed ID: 16314552
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
    Soriano V; Rivas P; Nuñez M
    Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of antiretroviral therapy on testosterone levels and fat-free mass.
    Collazos J
    Clin Infect Dis; 2007 Dec; 45(11):1525; author reply 1525-7. PubMed ID: 17990239
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality.
    Wyles DL
    Clin Infect Dis; 2008 Dec; 47(11):1476-8. PubMed ID: 18959495
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients.
    Khalili H; Dashti-Khavidaki S; Mohraz M; Etghani A; Almasi F
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):848-57. PubMed ID: 19551698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval prolongation and antiretroviral treatment: another point of interest.
    Chinello P; Petrosillo N
    Clin Infect Dis; 2007 May; 44(10):1388-9; author reply 1389-91. PubMed ID: 17443482
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral therapy increases risk of heart attack.
    Gottlieb S
    BMJ; 2003 Nov; 327(7425):1186. PubMed ID: 14630739
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of antiretroviral therapy on asymptomatic malaria parasitaemia in HIV-1 infected children.
    Adetifa IM; Akinsulie AO; Temiye EO; Iroha EO; Ezeaka VC; Mafe AG; Grange AO
    Niger Postgrad Med J; 2008 Sep; 15(3):141-5. PubMed ID: 18923585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
    Young J; Glass TR; Bernasconi E; Rickenbach M; Furrer H; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC;
    J Clin Epidemiol; 2009 Jun; 62(6):632-41. PubMed ID: 19108985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic.
    Banasch M; Knyhala K; Kollar S; Serova K; Potthoff A; Schlottmann R; Schmidt WE; Brockmeyer NH; Goetze O
    Eur J Med Res; 2008 Sep; 13(9):401-8. PubMed ID: 18948231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral nephrotoxicities.
    Atta MG; Deray G; Lucas GM
    Semin Nephrol; 2008 Nov; 28(6):563-75. PubMed ID: 19013327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
    de Perio MA; Gomez FJ; Frame PT; Fichtenbaum CJ
    AIDS; 2007 Oct; 21(16):2252-3. PubMed ID: 18090057
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
    Pasquier CJ; Moinard N; Sauné K; Souyris C; Lavit M; Daudin M; Izopet J; Bujan L
    AIDS; 2008 Sep; 22(14):1894-6. PubMed ID: 18753873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.